Ads
related to: exemestane inactivator 25 mg tab myl generic price comparison toolSCBN.org has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Exemestane is an irreversible, steroidal aromatase inactivator of type I, structurally related to the natural substrate 4-androstenedione. It acts as a false substrate for the aromatase enzyme, and is processed to an intermediate that binds irreversibly to the active site of the enzyme causing its inactivation, an effect also known as " suicide ...
Exemestane went through clinical trials in the 1990s and received FDA approval in 1999, marketed as Aromasin. Indication for exemestane is advanced breast cancer in postmenopausal women, where the cancer has progressed following tamoxifen therapy. Exemestane is the first oral aromatase inactivator. [5]
Prescription drug list prices in the United States continually are among the highest in the world. [1] [2] The high cost of prescription drugs became a major topic of discussion in the 21st century, leading up to the American health care reform debate of 2009, and received renewed attention in 2015.
Grocery price comparison apps are a great alternative, saving you time and money by showing you where to find the best deals. Check Out: Pocket an Extra $400 a Month With This Simple Hack.
Mylan received approval for sildenafil citrate tablets, 20 mg. Watson got the OK for sildenafil tablets, 20 mg, Revatio tablets, 20 mg, had almost $340 million in U.S. sales in the 12 months ended ...
Mylan (MYL) launches Ogivri, a biosimilar of Roche's blockbuster breast cancer drug, Herceptin (trastuzumab), in the United States.